Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Schizophrenia Research

• Publication date

  2015-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2015.03.033PMID 25868935PMCID PMC4437911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Missing data

  2019cited by this paper
• UCSD Performance-Based Skills Assessment

  2016cited by this paper
• Beck Depression Inventory.

  2016cited by this paper
• Structural Equations With Latent Variables

  2016cited by this paper
• Factors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies.

  2015cited by this paper
• Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later.

  2015cited by this paper
• The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.

  2014cited by this paper
• The influence of illness‐related variables, personal resources and context‐related factors on real‐life functioning of people with schizophrenia

  2014cited by this paper
• Social Competence Versus Negative Symptoms as Predictors of Real World Social Functioning in Schizophrenia

  2014cited by this paper
• Self-assessment of functional ability in schizophrenia: milestone achievement and its relationship to accuracy of self-evaluation.

  2013cited by this paper
• Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia.

  2013cited by this paper
• The social cognition psychometric evaluation study: results of the expert survey and RAND panel.

  2013cited by this paper
• A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes

  2012cited by this paper
• Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior.

  2012influential reference
• Functional milestones and clinician ratings of everyday functioning in people with schizophrenia: overlap between milestones and specificity of ratings.

  2012influential reference
• Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia.

  2012cited by this paper
• The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis.

  2011influential reference
• A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia.

  2011cited by this paper
• A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes.

  2011cited by this paper
• Validating the measurement of real-world functional outcomes: phase I results of the VALERO study.

  2011influential reference
• Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?

  2009cited by this paper
• Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden.

  2009cited by this paper
• Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

  2009cited by this paper
• Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms.

  2009cited by this paper
• Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study

  2008cited by this paper
• An Introduction to Applied Multivariate Analysis

  2008cited by this paper
• Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.

  2008influential reference
• Negative symptoms and cognitive deficits: what is the nature of their relationship?

  2006cited by this paper
• Barriers to employment for people with schizophrenia.

  2006cited by this paper
• Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

  2006influential reference
• On Multilevel Model Reliability Estimation From the Perspective of Structural Equation Modeling

  2006cited by this paper
• Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

  2004cited by this paper
• UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

  2001cited by this paper
• Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

  2000cited by this paper
• Cutoff criteria for fit indexes in covariance structure analysis : Conventional criteria versus new alternatives

  1999cited by this paper
• The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

  1998influential reference
• The mini international neuropsychiatric interview

  1998cited by this paper
• One hundred years of schizophrenia: a meta-analysis of the outcome literature.

  1994cited by this paper
• One hundred years of schizophrenia: A meta-analysis of the outcome literature

  1993cited by this paper
• Positive and Negative Syndromes in Schizophrenia: Assessment and Research

  1992cited by this paper
• The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

  1992cited by this paper
• Posthospital course and outcome in schizophrenia.

  1991cited by this paper
• National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.

  1991cited by this paper
• SLOF: a behavioral rating scale for assessing the mentally ill.

  1983cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Frontotemporal cortical thinning and insular surface area reduction in schizophrenia with predominant negative symptoms.

  2026cites this paper
• Predictions of different elements of everyday functional outcomes in bipolar disorder and schizophrenia: Cognition, social cognition, clinical symptoms, and mood states as predictors.

  2026cites this paper
• Del delirio a la flexibilidad psicológica: aplicación de la terapia de aceptación y compromiso

  2025cites this paper
• Digital phenotyping of social functioning and employment in people with schizophrenia: Pilot data from an international sample

  2025cites this paper
• Effect of Probiotics on C-Reactive Protein Levels in Schizophrenia: Evidence from a Systematic Review and Meta-Analysis.

  2025cites this paper
• Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

  2025cites this paper
• Real-world conversations across the schizophrenia spectrum: Implementing passive audio sensing to examine linguistic style matching.

  2025cites this paper
• Social Cognition and Social Inclusion in Young People With First‐Episode Psychosis: A Brief Report

  2025cites this paper
• An exploratory study on the relationship between personal recovery and social functioning in outpatients with schizophrenia

  2025cites this paper
• Measuring the clinical dimensions of negative symptoms through the Positive and Negative Syndrome Scale.

  2025cites this paper
• Engagement of people diagnosed with schizophrenia in a five-month exercise program: CORTEX-SP study

  2024cites this paper
• The effect of exercise on cognition and clinical symptoms of patients with schizophrenia: A systematic review of randomized controlled trial.

  2024cites this paper
• Impact of psychopathology on day-to-day living in patients with schizophrenia: A network analysis.

  2024cites this paper
• The Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia: A Targeted Literature Review With a Focus on Outcomes Relevant to Health Care Decision-Makers in the United States.

  2024cites this paper
• On the Road to Individualizing Pharmacotherapy for Adolescents and Adults with Schizophrenia – Results from an Expert Consensus Following the Delphi Method

  2024cites this paper
• Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength.

  2024cites this paper
• Autistic trait severity in early schizophrenia: Role in subjective quality of life and social functioning.

  2024cites this paper
• The implementation and effectiveness of Integrated Psychological Therapy (IPT) in chronic middle-aged inpatients with schizophrenia

  2024cites this paper
• Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition

  2024cites this paper
• Interpersonal consequences of paranoid ideation, negative symptoms and sleep problems in a transdiagnostic sample of individuals with psychosis.

  2024cites this paper
• The Role of Intolerance of Uncertainty and Religiousness in Schizotypal Personality and Life Satisfaction: A Cross-Sectional Study

  2024cites this paper
• Systematic review and meta-analysis on predictors of prognosis in patients with schizophrenia spectrum disorders: An overview of current evidence and a call for prospective research and open access to datasets.

  2023cites this paper
• Analyzing structural and functional brain changes related to an integrative cognitive remediation program for schizophrenia: A randomized controlled trial.

  2023cites this paper
• The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial

  2023cites this paper
• Paeonol, the active component of Cynanchum paniculatum, ameliorated schizophrenia-like behaviors by regulating the PI3K-Akt-GSK3β-NF-κB signalling pathway in MK-801-treated mice.

  2023cites this paper
• What factors should we modify to promote high functioning and prevent functional decline in people with schizophrenia?

  2023cites this paper
• Neurobehavioral indices of gaze perception are associated with social cognition across schizophrenia patients and healthy controls.

  2023cites this paper
• Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study

  2023cites this paper
• Immediate post performance judgements about cognitive performance in schizophrenia and bipolar disorder: associations with test performance and subjective overall judgments regarding abilities

  2023cites this paper
• Schizophrenia, Curcumin and Minimizing Side Effects of Antipsychotic Drugs: Possible Mechanisms

  2022cites this paper
• The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis.

  2022cites this paper
• Cluster analysis of negative symptoms identifies distinct negative symptom subgroups.

  2022cites this paper
• Perceptions of and subjective difficulties with social cognition in schizophrenia from an internet survey: Knowledge, clinical experiences, and awareness of association with social functioning

  2022cites this paper
• Theories and models of negative symptoms in schizophrenia and clinical implications

  2022cites this paper
• Occupational intervention in mental health hospitals: Study of contextual impact

  2022cites this paper
• The Important Role of Motivation and Pleasure Deficits on Social Functioning in Patients With Schizophrenia: A Network Analysis.

  2022cites this paper
• Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study

  2022cites this paper
• The Puzzle of Functional Recovery in Schizophrenia-Spectrum Disorders—Replicating a Network Analysis Study

  2022cites this paper
• Social cognition, neurocognition, symptomatology, functional competences and outcomes in people with schizophrenia - A network analysis perspective.

  2021cites this paper
• The effects of aerobic, strength, or mixed exercise programs on schizophrenia symptomatology: a randomized clinical trial with a 10-month follow-up

  2021cites this paper
• Cognitive, creative, functional, and clinical symptom improvements in schizophrenia after an integrative cognitive remediation program: a randomized controlled trial

  2021cites this paper
• Virtual reality interventions to improve cognitive functioning in adults with major psychiatric disorders: A narrative systematic review (Preprint)

  2021cites this paper
• Correlates of real-world goal-directed behavior in schizophrenia

  2021cites this paper
• Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia

  2021cites this paper
• Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses

  2021cites this paper
• Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning

  2021cites this paper
• Beyond a blunted ERN - Biobehavioral correlates of performance monitoring in schizophrenia.

  2021cites this paper
• The short and long-term effects of aerobic, strength, or mixed exercise programs on schizophrenia symptomatology

  2021cites this paper
• Real world sedentary behavior and activity levels in patients with schizophrenia and controls: An ecological momentary assessment study.

  2021cites this paper
• Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses.

  2021cites this paper
• Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study.

  2021cites this paper
• The interplay between functioning problems and symptoms in first episode of psychosis: An approach from network analysis.

  2021cites this paper
• The impact of creativity on functional outcome in schizophrenia: a mediational model

  2021cites this paper
• Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development

  2021cites this paper
• Self-reported social functioning and social cognition in schizophrenia and bipolar disorder: Using ecological momentary assessment to identify the origin of bias.

  2021cites this paper
• Impact of Negative Symptom Domains and Other Clinical Characteristics on Functional Outcomes in Patients with Schizophrenia

  2021cites this paper
• Predicting Real-World Functioning in Schizophrenia: The Relative Contributions of Neurocognition, Functional Capacity, and Negative Symptoms

  2021cites this paper
• Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.

  2021cites this paper
• Association of depressive symptoms with cognitive impairment in patients with never-treated first-episode schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study.

  2021cites this paper
• Cooperative Studies Program (CSP) #572: A Study of Serious Mental Illness in Veterans as a Pathway to personalized medicine in Schizophrenia and Bipolar Illness.

  2021cites this paper
• Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague–Dawley Rats

  2021cites this paper
• Predictors of social functioning and quality of life in schizophrenia and autism spectrum disorder.

  2021cites this paper
• Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms

  2021cites this paper
• Altered brain activity in the bilateral frontal cortices and neural correlation with cognitive impairment in schizophrenia

  2021cites this paper
• Everyday flexibility and functional milestones in anorexia nervosa: survey results from a mixed community sample

  2021cites this paper
• Addressing negative symptoms in schizophrenia through Metacognitive Reflection and Insight Therapy: An illustrated Case Study

  2021cites this paper
• The relationship between cognition and functioning in schizophrenia: A semi-systematic review

  2021cites this paper
• Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms: A randomized controlled trial.

  2021cites this paper
• Metacognition Is Uniquely Related to Concurrent and Prospective Assessments of Negative Symptoms Independent of Verbal Memory in Serious Mental Illness

  2020cites this paper
• Cognition, Social Cognition, and Functional Capacity in Early-Onset Schizophrenia.

  2020cites this paper
• Neurocognition and Social Cognition Predicting 1-Year Outcomes in First-Episode Psychosis

  2020cites this paper
• Effectiveness of integrated psychological therapy on cognitive function among Lebanese patients with schizophrenia: a pilot study

  2020cites this paper
• Emerging 5-HT receptor antagonists for the treatment of Schizophrenia

  2020cites this paper
• White Matter Microstructural Properties Associated with Impaired Attention in Chronic Schizophrenia: A Multi-Center Study.

  2020cites this paper
• Evaluation of executive functions and everyday life for people with severe mental illness: A systematic review

  2020cites this paper
• Diverse roles of mtDNA in schizophrenia: Implications in its pathophysiology and as biomarker for cognitive impairment.

  2020cites this paper
• Investigating Cognitive and Clinical Predictors of Real-Life Functioning, Functional Capacity, and Quality of Life in Individuals at Ultra-High Risk for Psychosis

  2020cites this paper
• Neighborhood socioeconomic status and racial disparities in schizophrenia: An exploration of domains of functioning.

  2020cites this paper
• A short history of individual placement and support in Norway.

  2020cites this paper
• Negative Symptoms and Their Assessment in Schizophrenia and Related Disorders

  2020cites this paper
• Stem Cells for Improving the Treatment of Neurodevelopmental Disorders

  2020cites this paper
• Evaluation of the Efficacy of BI 425809 Pharmacotherapy in Patients with Schizophrenia Receiving Computerized Cognitive Training: Methodology for a Double-blind, Randomized, Parallel-group Trial

  2020cites this paper
• Neurocognitive variability in schizophrenia spectrum disorders: relationship to real-world functioning

  2020influential citation
• Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures.

  2020cites this paper
• Pathways from performance monitoring to negative symptoms and functional outcomes in psychotic disorders

  2020cites this paper
• The Relationship between Negative Symptoms and Both Emotion Management and Non-social Cognition in Schizophrenia Spectrum Disorders

  2020cites this paper
• Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia

  2020cites this paper
• Social anxiety and negative symptoms as the characteristics of patients with schizophrenia who show competence–performance discrepancy in social functioning

  2019cites this paper
• Differential improvement of negative-symptom subfactors after cognitive remediation in low-functioning individuals with schizophrenia

  2019cites this paper
• Impaired insight in psychotic disorder: an unmet need in treatment

  2019cites this paper
• Autism symptoms, depression, and active social avoidance in schizophrenia: Association with self-reports and informant assessments of everyday functioning.

  2019cites this paper
• Depression and reduced emotional experience in schizophrenia: Correlations with self-reported and informant-rated everyday social functioning

  2019cites this paper
• A systematic review of factors that influence the efficacy of cognitive remediation therapy in schizophrenia

  2019cites this paper
• Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning

  2019cites this paper
• Modulation of extrasynaptic GABAA alpha 5 receptors in the ventral hippocampus normalizes physiological and behavioral deficits in a circuit specific manner

  2019cites this paper
• Psychological wellness, yoga and quality of life in patients affected by schizophrenia spectrum disorders: A pilot study

  2019cites this paper
• Association between mitochondrial DNA and cognitive impairment in schizophrenia: study protocol for a Mexican population

  2019cites this paper
• Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology.

  2019cites this paper
• Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment

  2019influential citation
• Associations Of Personality Traits With The Capacity-Performance Discrepancy Of Functional Outcome In Patients With Schizophrenia

  2019cites this paper